Immunologic parameters and prognosis in cervical cancer patients treated with radiotherapy.
D000920:Antibody-Dependent Cell Cytotoxicity / Q000528:radiation effects; D002294:Carcinoma, Squamous Cell / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy; D005260:Female; D006801:Humans; D008213:Lymphocyte Activation / Q000528:radiation effects; D010835:Phytohemagglutinins / Q000494:pharmacology; D011379:Prognosis; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology / Q000528:radiation effects; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy
D010835:Phytohemagglutinins